Klöckner Pentaplast embarks on pharma capacity expansion of Brazil facility

Klöckner Pentaplast - Brazil facility

Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) is investing EUR 5 million into their Cotia, Brazil facility. The capacity expansion at its Brazilian location is to enable new products to be manufactured in the region.

This latest investment comes about two years after the addition of the fourth slitting line in Cotia, which increased the current site’s slitting capacity by ~4.000 tonnes/per year, according to kp. The new capability is expected to be operational from July 2019.

Tracey Peacock, President, Pharmaceutical & Medical Device Films at kp, commented: “We are seeing substantial growth in our high barrier product segments in South America in response to the increased temperature, moisture and oxygen sensitivity of new drugs. We are excited to support this key mega trend by adding significant capacity and technical capability to support new products into our Cotia facility”.


Subscribe to Get the Latest Updates from PRA  Please click here

Copyright (c) 2018 www.plasticsandrubberasia.com. All rights reserved.